Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide Dosing for AMS Prevention
NCT01993667Phase 4Completed
- Sponsor
- University of Utah
- Start
- Mar 2012
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetazolamide in acute mountain sickness (AMS), sponsored by University of Utah. Started Mar 2012; status: completed.
02
Drugs
acetazolamide
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on NCT01993667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01993667.